Invention Grant
- Patent Title: Anti-ILT5 antibodies and ILT5-binding antibody fragments
- Patent Title (中): 抗ILT5抗体和ILT5结合抗体片段
-
Application No.: US13574307Application Date: 2011-01-20
-
Publication No.: US09023997B2Publication Date: 2015-05-05
- Inventor: Irina Apostolou , Paul Ponath , Joe Ponte , Michael Rosenzweig
- Applicant: Irina Apostolou , Paul Ponath , Joe Ponte , Michael Rosenzweig
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Gloria Fuentes; Immac Thampoe
- International Application: PCT/US2011/021939 WO 20110120
- International Announcement: WO2011/091177 WO 20110728
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; C07K16/28 ; C07K1/00 ; A61K39/00
Abstract:
Disclosed herein are antibodies and ILT5-binding fragments thereof that specifically bind to ILT5, e.g., human ILT5 (hILT5), and pharmaceutical compositions comprising such ILT5-binding antibodies and ILT5-binding fragments thereof.
Public/Granted literature
- US20130030156A1 ANTI-ILT5 ANTIBODIES AND ILT5-BINDING ANTIBODY FRAGMENTS Public/Granted day:2013-01-31
Information query
